One Biosciences develops clinical-grade single-cell tumor profiling and AI-powered analysis for precision oncology
One Biosciences develops clinical-grade single-cell tumor profiling and AI-powered analysis for precision oncology. Its OneMap platform analyzes clinical biopsy samples, including FFPE and frozen tissue, to generate reports and functional signatures that support treatment selection, biomarker discovery, patient stratification, and clinical trial optimization.